Literature DB >> 27500866

The presence of heterogeneous nuclear ribonucleoproteins in frontotemporal lobar degeneration with FUS-positive inclusions.

Priya Gami-Patel1, Rina Bandopadhyay1, Jack Brelstaff1, Tamas Revesz1, Tammaryn Lashley2.   

Abstract

Frontotemporal lobar degeneration with fused in sarcoma-positive inclusions (FTLD-FUS) is a disease with unknown cause. Transportin 1 is abundantly found in FUS-positive inclusions and responsible for the nuclear import of the FET proteins of which FUS is a member. The presence of all FET proteins in pathological inclusions suggests a disturbance of transportin 1-mediated nuclear import. FUS also belongs to the heterogeneous nuclear ribonucleoprotein (hnRNP) protein family. We investigated whether hnRNP proteins are associated with FUS pathology implicating dysfunctional nuclear export in the pathogenesis of FTLD-FUS. hnRNP proteins were investigated in affected brain regions in FTLD-FUS using immunohistochemistry, biochemical analysis, and the expression analysis. We demonstrated the presence of several hnRNP proteins in pathological inclusions including neuronal cytoplasmic inclusions and dystrophic neurites. The biochemical analysis revealed a shift in the location of hnRNP A1 from the nucleus to the cytoplasm. The expression analysis revealed an increase in several hnRNP proteins in FTLD-FUS. These results implicate a wider dysregulation of movement between intracellular compartments, than mechanisms only affecting the nuclear import of FUS proteins. Crown
Copyright © 2016. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FET proteins; FUS; Frontotemporal dementia; NanoString; Transportin; hnRNP

Mesh:

Substances:

Year:  2016        PMID: 27500866     DOI: 10.1016/j.neurobiolaging.2016.07.004

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors.

Authors:  Imke Baade; Saskia Hutten; Erin L Sternburg; Marius Pörschke; Mario Hofweber; Dorothee Dormann; Ralph H Kehlenbach
Journal:  J Biol Chem       Date:  2021-04-12       Impact factor: 5.157

Review 2.  RNA modulates physiological and neuropathological protein phase transitions.

Authors:  Jacob R Mann; Christopher J Donnelly
Journal:  Neuron       Date:  2021-07-22       Impact factor: 18.688

3.  Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in Semantic Dementia but not with other TDP-43 pathological subtypes of Frontotemporal Lobar Degeneration.

Authors:  Yvonne S Davidson; Andrew C Robinson; Louis Flood; Sara Rollinson; Bridget C Benson; Yasmine T Asi; Anna Richardson; Matthew Jones; Julie S Snowden; Stuart Pickering-Brown; Tammaryn Lashley; David M A Mann
Journal:  Acta Neuropathol Commun       Date:  2017-06-30       Impact factor: 7.801

4.  Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases.

Authors:  Anja Kahl; Ismary Blanco; Katherine Jackman; Juhi Baskar; Harihar Milaganur Mohan; Reunet Rodney-Sandy; Sheng Zhang; Costantino Iadecola; Karin Hochrainer
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

5.  Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.

Authors:  Lauren M Gittings; Sandrine C Foti; Bridget C Benson; Priya Gami-Patel; Adrian M Isaacs; Tammaryn Lashley
Journal:  Acta Neuropathol Commun       Date:  2019-02-12       Impact factor: 7.801

Review 6.  The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Alexander Bampton; Lauren M Gittings; Pietro Fratta; Tammaryn Lashley; Ariana Gatt
Journal:  Acta Neuropathol       Date:  2020-08-03       Impact factor: 17.088

7.  Heterogeneous ribonuclear protein A3 (hnRNP A3) is present in dipeptide repeat protein containing inclusions in Frontotemporal Lobar Degeneration and Motor Neurone disease associated with expansions in C9orf72 gene.

Authors:  Yvonne S Davidson; Louis Flood; Andrew C Robinson; Yoshihiro Nihei; Kohji Mori; Sara Rollinson; Anna Richardson; Bridget C Benson; Matthew Jones; Julie S Snowden; Stuart Pickering-Brown; Christian Haass; Tammaryn Lashley; David M A Mann
Journal:  Acta Neuropathol Commun       Date:  2017-04-21       Impact factor: 7.801

Review 8.  Heterogeneous Nuclear Ribonucleoproteins: Implications in Neurological Diseases.

Authors:  Yi-Hua Low; Yasmine Asi; Sandrine C Foti; Tammaryn Lashley
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

9.  Divergent FUS phosphorylation in primate and mouse cells following double-strand DNA damage.

Authors:  Michelle A Johnson; Qiudong Deng; Georgia Taylor; Zachary T McEachin; Anthony W S Chan; Jessica Root; Gary J Bassell; Thomas Kukar
Journal:  Neurobiol Dis       Date:  2020-09-18       Impact factor: 5.996

10.  Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells.

Authors:  Amber Anees; Hannah E Salapa; Patricia A Thibault; Catherine Hutchinson; S Austin Hammond; Michael C Levin
Journal:  eNeuro       Date:  2021-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.